Mutational and expressional analyses of MYD88 gene in common solid cancers

Tumori

Volumn 98, Issue 5, 2012, Pages 663-669

  Je, Eun Mi ^a   Kim, Sung Soo ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Colon cancer; Expression; Gastric cancer; Mutation; MYD88

Indexed keywords

GENOMIC DNA; MYELOID DIFFERENTIATION FACTOR 88;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC GAIN; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MUTATIONAL ANALYSIS; MYD88 GENE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SINGLE STRANDED CONFORMATION POLYMORPHISM; SOMATIC MUTATION; STOMACH CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84872085740     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1190.13209     Document Type: Article

References (17)

1. Lord KA, Hoffman-Liebermann B, Liebermann DA: Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants. Oncogene, 5: 387-396, 1990.
2. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr.: MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell, 2: 253-258, 1998.
3. Muzio M, Ni J, Feng P, Dixit VM: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science, 278: 1612-1615, 1997.
4. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature, 410: 1099-1103, 2001.
5. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y: Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol, 170: 3977-3985, 2003.
6. Li GZ, Zhang Y, Zhao JB, Wu GJ, Su XF, Hang CH: Expression of myeloid differentiation primary response protein 88 (Myd88) in the cerebral cortex after experimental traumatic brain injury in rats. Brain Res, 1396: 96-104, 2011.
7. Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T, Drew AF: Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother, 58: 1375-1385, 2009.
8. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM: Oncogenically active MYD88 mutations in human lymphoma. Nature, 470: 115-119, 2011.
9. Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz M, Bassaganyas L, Baumann T, Juan M, López-Guerra M, Colomer D, Tubío JM, López C, Navarro A, Tornador C, Aymerich M, Rozman M, Hernández JM, Puente DA, Freije JM, Velasco G, Gutiérrez- Fernández A, Costa D, Carrió A, Guijarro S, Enjuanes A, Hernández L, Yagüe J, Nicolás P, Romeo-Casabona CM, Himmelbauer H, Castillo E, Dohm JC, de Sanjosé S, Piris MA, de Alava E, San Miguel J, Royo R, Gelpí JL, Torrents D, Orozco M, Pisano DG, Valencia A, Guigó R, Bayés M, Heath S, Gut M, Klatt P, Marshall J, Raine K, Stebbings LA, Futreal PA, Stratton MR, Campbell PJ, Gut I, López-Guillermo A, Estivill X, Montserrat E, López-Otín C, Campo E: Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature, 475: 101-105, 2011.
10. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA: Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476: 298-303, 2011.
11. Coste I, Le Corf K, Kfoury A, Hmitou I, Druillennec S, Hainaut P, Eychene A, Lebecque S, Renno T: Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J Clin Invest, 120: 3663-3667, 2010.
12. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T: High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer, 102: 908-915, 2010.
13. Silasi DA, Alvero AB, Illuzzi J, Kelly M, Chen R, Fu HH, Schwartz P, Rutherford T, Azodi M, Mor G: MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer. Yale J Biol Med, 79: 153-163, 2006.
14. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ: Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene, 18: 3754-3760, 1999.
15. Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH: PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene, 24: 1477-1480, 2005.
16. Gong J, Xu J, Zhu W, Gao X, Li N, Li J: Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clin Immunol, 136: 245-256, 2010.
17. Drasar BS, Shiner M, McLeod GM: Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology, 56: 71-79, 1969.